Quick Answer
STANDARD BIOTOOLS INC. reported Cash And Cash Equivalents At Carrying Value of $120.86 million for the year ending 2025.
- STANDARD BIOTOOLS INC. showed a decrease of -27.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from STANDARD BIOTOOLS INC.'s annual report (Form 10-K), filed with the SEC on March 16, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), STANDARD BIOTOOLS INC.'s Cash And Cash Equivalents At Carrying Value has grown by 579.2%.
- Historical annual values: Fiscal year 2025: $120.86 million | Fiscal year 2024: $166.73 million | Fiscal year 2023: $51.70 million | Fiscal year 2022: $81.31 million | Fiscal year 2021: $28.45 million | Fiscal year 2020: $68.52 million | Fiscal year 2019: $21.66 million | Fiscal year 2018: $95.40 million | Fiscal year 2017: $58.06 million | Fiscal year 2016: $35.05 million | Fiscal year 2015: $29.12 million | Fiscal year 2014: $33.71 million | Fiscal year 2013: $35.26 million | Fiscal year 2012: $58.65 million | Fiscal year 2011: $13.55 million | Fiscal year 2010: $5.72 million | Fiscal year 2009: $14.60 million | Fiscal year 2008: $17.80 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: